HIV prevention with drug using populations. Current status and future prospects.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


HIV prevention with drug using populations. Current status and future prospects.

  • Published Date:

    Jun 1998

  • Source:
    Public Health Rep. 113(Suppl 1):1-3
  • Language:
    English
Filetype[PDF-413.01 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Filetype[PDF - 135.73 KB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      The National Institute on Drug Abuse (NIDA), in collaboration with the Office of AIDS Research of the National Institutes of Health, invited national ...
      File Type:
      Filetype[PDF - 135.73 KB]
      File Type:
      Filetype[PDF - 135.73 KB]
    2. Filetype[PDF - 1.18 MB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      Description:
      HIV prevention with drug-using populations : current status and future prospects
      File Type:
      Filetype[PDF - 1.18 MB]
      File Type:
      Filetype[PDF - 1.18 MB]
    3. Filetype[PDF - 7.12 MB]
      Personal Author:
      Cottler, L B ; Compton, W M ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):31-41
      Description:
      The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-...
      File Type:
      Filetype[PDF - 7.12 MB]
      File Type:
      Filetype[PDF - 7.12 MB]
    4. Filetype[PDF - 3.90 MB]
      Personal Author:
      Needle, R H ; Coyle, S L ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):4-18
      File Type:
      Filetype[PDF - 3.90 MB]
      File Type:
      Filetype[PDF - 3.90 MB]
    5. Filetype[PDF - 2.59 MB]
      Personal Author:
      Latkin, C A
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):151-159
      Description:
      Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunode...
      File Type:
      Filetype[PDF - 2.59 MB]
      File Type:
      Filetype[PDF - 2.59 MB]
    6. Filetype[PDF - 3.39 MB]
      Personal Author:
      Brooner, R ; Kidorf, M ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):129-139
      Description:
      Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other des...
      File Type:
      Filetype[PDF - 3.39 MB]
      File Type:
      Filetype[PDF - 3.39 MB]
    7. Filetype[PDF - 2.32 MB]
      Personal Author:
      Valente, T W ; Foreman, R K ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):90-96
      Description:
      Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or be...
      File Type:
      Filetype[PDF - 2.32 MB]
      File Type:
      Filetype[PDF - 2.32 MB]
    8. Filetype[PDF - 2.54 MB]
      Personal Author:
      Singer, M ; Baer, H A ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):81-89
      Description:
      To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sa...
      File Type:
      Filetype[PDF - 2.54 MB]
      File Type:
      Filetype[PDF - 2.54 MB]
    9. Filetype[PDF - 2.07 MB]
      Personal Author:
      Ball, A L ; Rana, S ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):170-181
      Description:
      Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. ...
      File Type:
      Filetype[PDF - 2.07 MB]
      File Type:
      Filetype[PDF - 2.07 MB]
    10. Filetype[PDF - 5.34 MB]
      Personal Author:
      Coyle, S L ; Needle, R H ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):19-30
      Description:
      Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) intervention...
      File Type:
      Filetype[PDF - 5.34 MB]
      File Type:
      Filetype[PDF - 5.34 MB]
    11. Filetype[PDF - 2.15 MB]
      Personal Author:
      Levy, J A ; Fox, S E ;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):160-169
      Description:
      This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users ...
      File Type:
      Filetype[PDF - 2.15 MB]
      File Type:
      Filetype[PDF - 2.15 MB]
    12. Filetype[PDF - 230.08 KB]
      Published Date:
      6-1998
      Source:
      Public Health Rep. 113(Suppl 1)
      File Type:
      Filetype[PDF - 230.08 KB]
      File Type:
      Filetype[PDF - 230.08 KB]
    13. Filetype[PDF - 2.90 MB]
      Personal Author:
      Booth, R E ; Kwiatkowski, C ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):116-128
      Description:
      High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors h...
      File Type:
      Filetype[PDF - 2.90 MB]
      File Type:
      Filetype[PDF - 2.90 MB]
    14. Filetype[PDF - 3.45 MB]
      Personal Author:
      Kumar, M S ; Mudaliar, S ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):58-66
      Description:
      Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this ch...
      File Type:
      Filetype[PDF - 3.45 MB]
      File Type:
      Filetype[PDF - 3.45 MB]
    15. Filetype[PDF - 1.90 MB]
      Personal Author:
      Vlahov, D ; Junge, B ;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):75-80
      Description:
      Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...
      File Type:
      Filetype[PDF - 1.90 MB]
      File Type:
      Filetype[PDF - 1.90 MB]
    16. Filetype[PDF - 780.81 KB]
      Personal Author:
      Shriver, M ; de Burger, R ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):189-193
      Description:
      Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the f...
      File Type:
      Filetype[PDF - 780.81 KB]
      File Type:
      Filetype[PDF - 780.81 KB]
    17. Filetype[PDF - 3.06 MB]
      Personal Author:
      Metzger, D S ; Navaline, H ; ...
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):97-106
      Description:
      As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider t...
      File Type:
      Filetype[PDF - 3.06 MB]
      File Type:
      Filetype[PDF - 3.06 MB]
    18. Filetype[PDF - 1.57 MB]
      Personal Author:
      Heimer, R
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):67-74
      Description:
      This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs...
      File Type:
      Filetype[PDF - 1.57 MB]
      File Type:
      Filetype[PDF - 1.57 MB]
    19. Filetype[PDF - 2.89 MB]
      Personal Author:
      Neaigus, A
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):140-150
      Description:
      To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The ...
      File Type:
      Filetype[PDF - 2.89 MB]
      File Type:
      Filetype[PDF - 2.89 MB]
    20. Filetype[PDF - 3.12 MB]
      Personal Author:
      Hartel, D M ; Schoenbaum, E E ;
      Published Date:
      Jun 1998
      Source:
      Public Health Rep. 113(Suppl 1):107-115
      Description:
      We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...
      File Type:
      Filetype[PDF - 3.12 MB]
      File Type:
      Filetype[PDF - 3.12 MB]

You May Also Like:

  1. Filetype[PDF - 2.40 MB]
    Personal Author:
    Sloboda, Z
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):194-204
    Description:
    After more than 10 years of experience conducting behavioral changes interventions and with accumulated research results, several emergent principle h...
    File Type:
    Filetype[PDF - 2.40 MB]
    File Type:
    Filetype[PDF - 2.40 MB]
  2. Filetype[PDF - 2.07 MB]
    Personal Author:
    Ball, A L ; Rana, S ; ...
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):170-181
    Description:
    Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. ...
    File Type:
    Filetype[PDF - 2.07 MB]
    File Type:
    Filetype[PDF - 2.07 MB]
  3. Filetype[PDF - 1.17 MB]
    Personal Author:
    Des Jarlais, D C ; Friedman, S R ;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):182-188
    Description:
    Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunode...
    File Type:
    Filetype[PDF - 1.17 MB]
    File Type:
    Filetype[PDF - 1.17 MB]